Hepatitis C virus leads to liver cirrhosis or cancer in people with hepatitis C infection. The world health organization (WHO) does not recommend the need for treatment in patients with first-time hepatitis C infection. However, chronic cases need to be treated with pan-genotypic direct-acting antivirals (DAAs) for a period of 12 to 24 weeks. These antivirals were so expensive in the previous years, making it difficult to buy and use among low-income people. But in recent times, they have become cost-effective.
All the answers published in this website are written by Verified medical doctors, therapists and health experts. The Content has been moderated by iCliniq medical review team before publication. Post your medical clarifications on iCliniq by choosing the right specialty and get them answered. Your medical queries will be answered 24/7 by top doctors from iCliniq.
Query: Hi doctor, Is tablet Hepcivir L effective for HCV positive patient? Is that safe for a heart patient? Read Full »
Answer: Hi, Welcome to icliniq.com. Cardiac side effect chance is not significant. Drug trial does not mention the cardiac side effect of this drug (Hepcivir L - a combination of Sofosbuvir and Ledipasvir). It means any cardiac side effect is likely to be less than 1% and cannot be attributed to this drug.... Read Full »
Query: Hi doctor, I am 40 years old. I was diagnosed with hepatitis C before 16 years while donating blood. No allopathy treatment was taken till last month. My liver function tests are monitored regularly. Most of the time, the result will be elevated levels of SGOT and SGPT of 200 and 300 respectively. B... Read Full »
Answer: Hi, Welcome to icliniq.com, We are here to help you. I would highly recommend you to continue the medicine for 12 weeks at least. You are very lucky that your viral load is undetectable just with these medicines, else most of the people with hepatitis C requires 6 to 12 months, if Interfer... Read Full »
Query: Hi doctor, My mother is 59 years old, with type 2 diabetes for the past 15 years. She is taking medications for diabetes, blood pressure and multivitamin Centrum Her diabetes and BP are under control. Before four months, she had severe vomiting, fever and body pain. We approached a hospital and did ... Read Full »
Answer: Hi, Welcome to icliniq.com. I went through your post and investigations (attachment removed to protect patient identity). Your mother is having hepatitis C, which if untreated can lead to liver failure and the treatment success rate is 95 to 99 %. The status of liver disease can be assessed by two m... Read Full »
The terms and conditions (hereinafter collectively referred to as, the "Terms of Service") set out herein shall be a legally binding Agreement between Orane Healthcare India Pvt. Ltd., a company incorporated under the Companies Act, 1956, having its registered office at No.174, Rangasamy Goundenpudur, Chinniyampalayam (PO), Coimbatore – 641062, Tamil Nadu, India (hereinafter interchangeably referred to as, "We" or "Us" or "Our" or the "Company" or "iCliniq"), and you (hereinafter referred to as, "You" or "Your"), as the Registered Doctor (defined below) or Registered Alternative Medicine Practitioner (defined below) or Wellness Professional (defined below) or User / Registered User (defined below) on the Platform (defined below) and/or the services offered through the Platform. The Platform is developed and maintained by the Company.
The Terms of Service shall govern your use of the Platform and its services offered through the Platform, therefore, please read and understand the Terms of Service before you access the services, view, download, install or Register with or use the Platform. If you are not agreeable to this Terms of Service, then you shall not access, view, download or install the Platform, or use the Platform or the services offered through the Platform, and if you are accessing, installing, using, or viewing the Platform, then you shall delete the account and desist from such accessing, using, installing or viewing the Platform.
PART – A
PART - B
PART - C
*Please check to continue futher